Adjuvant Chemotherapy Is Not Associated With Worse Disease-Free Survival In The Elderly Population.

L. B. Mendes Gomes,M. D. Spina Donadio,D. Maciel Santana,M. F. Evangelista Simoes,M. F. Barbosa De Medeiros,C. I. De Andrade Souza,M. Petrocchi Corassa,H. De Freitas,V. C. De Lima

Journal of Thoracic Oncology（2021）

引用 0|浏览1

暂无评分

摘要

Adjuvant chemotherapy after complete surgical resection is currently the standard of care for patients with stage IB-IIIA (7th Ed. TNM) non-small-cell lung cancer. The applicability of this treatment to the elderly population however is not completely established. This retrospective study evaluated the indication of adjuvant treatment and the influence of age on survival in patients over 65 years with stage I-III non-small-cell lung cancer.

查看译文

关键词

NSCLC, Adjuvant chemotherapy, Elderly

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要